Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride

Clinical trial NCT07010575 · COMPLETED

Trial details

NCT number: NCT07010575
Sponsor: Orphalan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Wilson's Disease

Start date: 2025-07-15
Primary completion: 2025-12-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.